Mutant polymerases for sequencing and genotyping

• US 20070048748A1
• Filed: 09/23/2005
• Published: 03/01/2007
• Est. Priority Date: 09/24/2004
• Status: Abandoned Application

• Current Assignee: Li & S Company Limited (Yesco Holdings Co., Ltd.)
• Original Assignee: Li & S Company Limited (Yesco Holdings Co., Ltd.)
• Inventors: Anderson, Jon, Steffens, David, Williams, John, Urlacher, Teresa
• Application Number:
  US11/234,677
• Publication Number:
  US 20070048748A1
• Time in Patent Office: Days
• US Class Current: 435/6
• CPC Class Codes: C12N 9/1252 DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase

Abstract

The invention relates to the discovery of novel mutant DNA polymerases that possess altered kinetics for incorporating phosphate-labeled nucleotides during polymerization. The invention further relates to the use of these mutant DNA polymerases in sequencing and genotyping methods.

Claims

1. A mutant DNA polymerase, wherein the amino acid sequence of the phosphate region of said mutant DNA polymerase comprises two or more mutations not present in the phosphate region of the most closely related native DNA polymerase, and wherein said two or more phosphate region mutations increase the rate at which said mutant DNA polymerase incorporates a phosphate-labeled nucleotide.

2. The mutant DNA polymerase of claim 1, wherein said mutant DNA polymerase, or at least the phosphate region of said mutant polymerase, is derived from a Family A or Family B polymerase.

3. The mutant DNA polymerase of claim 2, wherein said mutant polymerase is a Family B polymerase.

4. The mutant DNA polymerase of claim 3, wherein said mutant polymerase is a 9°

N DNA polymerase.

5. The mutant DNA polymerase of claim 4, wherein said mutant 9°

N DNA polymerase incorporates phosphate-labeled nucleotides at an increased rate relative to 9°

N-A485L DNA polymerase (SEQ ID NO;

     2); and

wherein said mutant 9°

N DNA polymerase comprises an alanine to leucine mutation at amino acid position 485; and

wherein said mutant 9°

N DNA polymerase further comprises one or more additional mutations in the phosphate region of said mutant 9°

N DNA polymerase.

6. The mutant 9°

N DNA polymerase of claim 5, wherein said one or more additional mutations are selected from the group consisting of a mutation at amino acid position 352, 355, 408, 460, 461, 464, 480, 483, 484, and 497, and combinations thereof.

7. The mutant 9°

N DNA polymerase of claim 5, wherein said one or more additional mutations comprises a mutation at amino acid position 484.

8. The mutant 9°

N DNA polymerase of claim 5, wherein said one or more additional mutations includes mutations at amino acid positions 408, 464, and 484.

9. The mutant 9°

N DNA polymerase of claim 8, wherein said mutation at position 408 is selected from the group consisting of tryptophan, glutamine, histidine glutamic acid, methionine, asparagine, lysine, and alanine; and

wherein said mutation at position 464 is selected from the group consisting of glutamic acid and proline; and

wherein said mutation at position 485 is tryptophan.

10. The mutant 9°

N DNA polymerase of claim 8, wherein said amino acids at positions 408, 464, and 484 are tryptophan, glutamic acid, and tryptophan, respectively.

11. The mutant 9°

N DNA polymerase of claim 5, wherein said mutant 9°

N DNA polymerase incorporates phosphate-labeled nucleotides at an increased rate relative to 9°

N-A485L DNA polymerase (SEQ ID NO;

     2), and wherein said rate is at least three times faster than that catalyzed by 9°

N-A485L DNA polymerase.

12. The mutant 9°

N DNA polymerase of claim 5, wherein said mutant 9°

N DNA polymerase incorporates phosphate-labeled nucleotides at an increased rate relative to 9°

N-A485L DNA polymerase (SEQ ID NO;

     2), and wherein said rate is at least seven times faster than that catalyzed by 9°

N-A485L DNA polymerase.

13. The mutant 9°

N DNA polymerase of claim 5, wherein said mutant 9°

N DNA polymerase incorporates phosphate-labeled nucleotides at an increased rate relative to 9°

N-A485L DNA polymerase (SEQ ID NO;

     2), and wherein said rate is at least twenty times faster than that catalyzed by 9°

N-A485L DNA polymerase.

14. The mutant 9°

N DNA polymerase of claim 5, wherein said mutant 9°

N DNA polymerase incorporates phosphate-labeled nucleotides at an increased rate relative to 9°

N-A485L DNA polymerase (SEQ ID NO;

     2), and wherein said rate is at least fifty times faster than that catalyzed by 9°

N-A485L DNA polymerase.

15. The mutant 9°

N DNA polymerase of SEQ ID NO. 568.

16. The mutant 9°

N DNA polymerase of SEQ ID NO. 568, further comprising one or more additional mutations, wherein said one or more additional mutations are selected from the group consisting of an alteration in amino acid identity, an insertion of one or more amino acids, and the deletion of one or more amino acids.

17. The mutant 9°

N DNA polymerase of SEQ ID NO. 568 and conservative modifications thereof.

18. The mutant 9°

N DNA polymerase of claim 17, further comprising one or more additional mutations, wherein at least one additional mutation is in the phosphate region of said mutant 9°

N DNA polymerase.

19. The mutant 9°

N DNA polymerase of claim 18, wherein the additionally mutated amino acid is selected from the group consisting of the asparagine at position 491 and lysine at position 487.

20. A mutant 9°

N DNA polymerase with an amino acid sequence selected from the group consisting of the even-numbered SEQ ID NOs 4 through 750.

21. A purified nucleic acid sequence encoding a polymerase of claim 20.

22. A method for identifying polymerases with improved suitability for a nucleotide sequencing process, wherein the improved suitability is measured relative to that of a parent polymerase, comprising:

(1) assaying the rate of phosphate-labeled nucleotide incorporation by a test mutant polymerase, wherein said phosphate region of said test polymerase is at least 90% identical to said parent polymerase;

(2) determining if said rate of phosphate-labeled nucleotide incorporation by said test mutant polymerase is suitable for said nucleotide sequencing process; and

,

if said rate of phosphate-labeled nucleotide incorporation is suitable, then identifying the test mutant polymerase as such.

23. The method of claim 22, wherein if said rate of phosphate-labeled nucleotide incorporation is not suitable, repeating steps (1) and (2) with a second test mutant polymerase until a suitable polymerase is identified.

24. The method of claim 23, wherein said second test mutant comprises each of the mutations in the previous test mutant polymerase, and further comprises at least one additional mutation relative to the previous test mutant polymerase.

25. The method of claim 22, wherein said polymerase is a thermostable polymerase.

26. The method of claim 22, wherein the amino acid sequence of said parent polymerase is at least 90% identical to the amino acid sequence of 9°

N-A485L DNA polymerase (SEQ ID NO;

     2).

27. The method of claim 22, wherein the amino acid sequence of said parent polymerase is at least 95% identical to the amino acid sequence of 9°

N-A485L DNA polymerase (SEQ ID NO;

     2).

28. The method of claim 26, wherein said improved polymerase is a polymerase which incorporates between 1 and 20 phosphate-labeled nucleotides per second.

29. The method of claim 28, wherein said improved polymerase is a polymerase which incorporates between 5 and 15 phosphate-labeled nucleotides per second.

30. The method of claim 29, wherein said nucleotide sequencing process is a field-switch polynucleotide sequencing process.

31. A mutant polymerase identified by the method of claim 24.

32. A mutant polymerase identified by the method of claim 27.

33. A mutant DNA polymerase, wherein the amino acid sequence of the phosphate region of said mutant DNA polymerase comprises one or more mutations not present in the phosphate region of the most closely related native DNA polymerase, and wherein said one or more phosphate region mutations increase the rate at which said mutant DNA polymerase incorporates a phosphate-labeled nucleotide.

34. The mutant DNA polymerase of claim 33, wherein said mutant DNA polymerase is a Family A DNA polymerase.

45. The mutant DNA polymerase of claim 34, wherein said mutant polymerase is a mutant Taq DNA polymerase.

35. The mutant DNA polymerase of claim 35, wherein said mutant polymerase is a mutant Klenow DNA polymerase.

36. The mutant DNA polymerase of claim 35, wherein said mutant Klenow polymerase incorporates phosphate-labeled nucleotides at an increased rate relative to the Klenow DNA polymerase of SEQ ID NO:

752; and

wherein said mutant Klenow DNA polymerase comprises one or more phosphate region mutations.

37. The mutant Klenow DNA polymerase of claim 36, wherein said one or more additional mutations are selected from the group consisting of a mutation at amino acid position 423 and 504, and combinations thereof.

38. The mutant Klenow DNA polymerase of claim 37, wherein the amino acid at position 423 is mutated.

39. The mutant Klenow DNA polymerase of claim 38, wherein the amino acid at position 504 is mutated.

40. The mutant Klenow DNA polymerase of claim 39, wherein the amino acid at position 423 is lysine or glutamic acid.

41. The mutant Klenow DNA polymerase of claim 40, wherein the amino acid at position 504 is glycine.

42. The mutant Klenow DNA polymerase of claim 41, wherein said mutant polymerase incorporates phosphate-labeled nucleotides at a rate at least three times faster than the Klenow polymerase of SEQ ID NO:

752.

70. The method of claim 69, wherein said mutant DNA polymerase is selected from the group consisting of any of the mutants set forth in claims 5, 36, and 46.

43. The mutant Klenow DNA polymerase of SEQ ID NO:

756, 758, or 764.

44. A purified nucleotide acid encoding a mutant Klenow DNA polymerase of claim 43.

46. The mutant DNA polymerase of claim 43, wherein said mutant Taq DNA polymerase incorporates phosphate-labeled nucleotides at an increased rate relative to the Taq DNA polymerase of SEQ ID NO:

766; and

wherein said mutant Taq DNA polymerase comprises one or more phosphate region mutations.

47. The mutant Taq DNA polymerase of claim 46, wherein said one or more additional mutations are selected from the group consisting of a mutation at amino acid positions 589, 617, 645, 691, 673, and 726, and combinations thereof.

48. The mutant Taq DNA polymerase of claim 47, wherein the amino acid at position 617 is isoleucine.

49. The mutant Taq DNA polymerase of claim 47, wherein the amino acid at position 645 is selected from the group consisting of histidine, phenylalanine, lysine and tryptophan.

50. The mutant Taq DNA polymerase of claim 47, wherein the amino acid at position 691 is tyrosine.

51. The mutant Taq DNA polymerase of claim 47, wherein the amino acid at position 693 is glycine.

52. The mutant Taq DNA polymerase of claim 47, wherein the amino acid at position 726 is serine.

53. The mutant Taq DNA polymerase of claim 47, wherein the amino acid at position 589 is aspartic acid and the amino acid at position 645 is histidine.

54. The mutant Taq DNA polymerase of claim 47, wherein said mutant polymerase incorporates phosphate-labeled nucleotides at a rate at least two times faster than the Taq polymerase of SEQ ID NO:

766.

55. The mutant Taq DNA polymerase of claim 47, wherein said mutant polymerase incorporates phosphate-labeled dinucleotides at a rate between five and fifteen times faster than the Taq polymerase of SEQ ID NO:

766.

56. The mutant Taq DNA polymerase of SEQ ID NO:

768, 770, 772, 774, 776, 778, 780, 782 or 784.

57. A purified nucleic acid encoding a mutant Taq DNA polymerase of claim 56.

58. A mutant DNA polymerase selected from the group consisting of the mutant DNA polymerases represented by the even-numbered sequences of SEQ ID NOs:

4-750, 754-764, and 768-784.

59. A mutant DNA polymerase wherein the phosphate region of said mutant DNA polymerase is identical to the phosphate region of a polymerase selected from the group consisting of the mutant DNA polymerases represented by the even-numbered sequences of SEQ ID NOs:

4-750, 754-764, and 768-784.

60. A mutant DNA polymerase selected from the group consisting of the mutant DNA polymerases represented by the even-numbered sequences of SEQ ID NOs:

4-750, wherein said mutant DNA polymerase incorporates phosphate-labeled nucleotides at an increased rate relative to the DNA polymerase of SEQ ID NO;

2.

63. The mutant polymerase of claims 60, 61 or 62, further comprising at least one anchor for attachment to a solid surface.

64. The mutant polymerase of claim 63, wherein said polymerase has at least two anchors.

65. The mutant DNA polymerase of claim 63, wherein said mutant DNA polymerase is used for DNA sequencing and genotyping.

66. The mutant DNA polymerase of claim 65, wherein said DNA sequencing is selected from the group consisting of charge-switch sequencing and electrokinetic sequencing.

67. The mutant DNA polymerase of claim 65, wherein said DNA sequencing is single DNA molecule sequencing.

68. The mutant DNA polymerase of claim 65, wherein said DNA genotyping is single DNA molecule genotyping.

61. A mutant DNA polymerase selected from the group consisting of the mutant DNA polymerases represented by the even-numbered sequences of SEQ ID NOs:

754-764, wherein said mutant DNA polymerase incorporates phosphate-labeled nucleotides at an increased rate relative to the DNA polymerase of SEQ ID NO;

752.

62. A mutant DNA polymerase selected from the group consisting of the mutant DNA polymerases represented by the even-numbered sequences of SEQ ID NOs:

768-784, wherein said mutant DNA polymerase incorporates phosphate-labeled nucleotides at an increased rate relative to the DNA polymerase of SEQ ID NO;

766.

69. A method of DNA sequencing, said method comprising:

(i) providing at least one complex comprising a target nucleic acid, a primer nucleic acid, and a mutant DNA polymerase;

(ii) contacting the complex with a plurality of charged particles comprising at least one type of phosphate-labeled nucleotide triphosphate (NTP) by applying an electric field;

(iii) reversing the electric field to transport unbound charged particles away from the surface; and

(iv) detecting the incorporation of said at least one type of γ

-phosphate-labeled NTP into a single molecule of the primer nucleic acid.

71. The method of claim 69, wherein said phosphate-labeled NTP is a γ

-phosphate-labeled NTP.

72. The method of claim 71, wherein said γ

-phosphate-labeled NTP is further labeled with polyethylene glycol (PEG).